Cardiac Troponin and Outcome in Acute Heart Failure
Top Cited Papers
- 15 May 2008
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (20) , 2117-2126
- https://doi.org/10.1056/nejmoa0706824
Abstract
Cardiac troponin provides diagnostic and prognostic information in acute coronary syndromes, but its role in acute decompensated heart failure is unclear. The purpose of our study was to describe the association between elevated cardiac troponin levels and adverse events in hospitalized patients with acute decompensated heart failure. We analyzed hospitalizations for acute decompensated heart failure between October 2001 and January 2004 that were recorded in the Acute Decompensated Heart Failure National Registry (ADHERE). Entry criteria included a troponin level that was obtained at the time of hospitalization in patients with a serum creatinine level of less than 2.0 mg per deciliter (177 μmol per liter). A positive troponin test was defined as a cardiac troponin I level of 1.0 μg per liter or higher or a cardiac troponin T level of 0.1 μg per liter or higher. Troponin was measured at the time of admission in 84,872 of 105,388 patients (80.5%) who were hospitalized for acute decompensated heart failure. Of these patients, 67,924 had a creatinine level of less than 2.0 mg per deciliter. Cardiac troponin I was measured in 61,379 patients, and cardiac troponin T in 7880 patients (both proteins were measured in 1335 patients). Overall, 4240 patients (6.2%) were positive for troponin. Patients who were positive for troponin had lower systolic blood pressure on admission, a lower ejection fraction, and higher in-hospital mortality (8.0% vs. 2.7%, P<0.001) than those who were negative for troponin. The adjusted odds ratio for death in the group of patients with a positive troponin test was 2.55 (95% confidence interval, 2.24 to 2.89; P<0.001 by the Wald test). In patients with acute decompensated heart failure, a positive cardiac troponin test is associated with higher in-hospital mortality, independently of other predictive variables. (ClinicalTrials.gov number, NCT00366639.)Keywords
This publication has 18 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- ED patients with heart failure: identification of an observational unit–appropriate cohortThe American Journal of Emergency Medicine, 2006
- Predictors of Emergency Department Observation Unit OutcomesAcademic Emergency Medicine, 2005
- Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart FailureClassification and Regression Tree AnalysisJAMA, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunctionScandinavian Journal of Clinical and Laboratory Investigation, 2004
- Circulating concentrations of cardiac proteins indicate the severity of congestive heart failureHeart, 2003
- Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart FailureCirculation, 2003
- Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failureThe American Journal of Cardiology, 2002
- Cardiac troponins in congestive heart failureAmerican Heart Journal, 1999